View Filing Data

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Schedule of Credit Facilities

Credit Facilities (Tables)

6 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

A summary of our loan facilities and subordinated debt financing as of March 31, 2019 is as follows:



	As of March 31, 2019
Lender	Arrangement	Loan Balance		Interest	Maturity Date
Fifth Third Bank	Secured term loan $25 million (a)	$	—	LIBOR* + 3.0%	5/1/2021
Fifth Third Bank	Secured revolving line of credit $10 million ceiling (b)	$	—	LIBOR* + 3.0%	5/1/2021

*LIBOR rate as of March 31, 2019 was 2.49%

Stock-based Compensation, Equity Grants, and Warrants (Tables)

6 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense, shown in the table below, is recorded in general and administrative expenses included in our statement of operations:



		(in thousands)				(in thousands)
		Three Months Ended				Six Months Ended
	Ref	March 31,				March 31,
		2019		2018		2019		2018
DLH employees	(a)	$	67	$	67	$	129	$	131
Non-employee directors	(b)	132		104		263		797
Total stock option expense		$	199	$	171	$	392	$	928

Ref (a): Equity grants of 35,000 stock options were made in the second quarter of fiscal year 2019 to employees in accordance with DLH compensation policy.

Unrecognized stock-based compensation expense



		(in thousands)
		March 31,
	Ref	2019
Unrecognized expense for DLH employees	(a)	$	766
Unrecognized expense for non-employee directors	(b)	263
Total unrecognized expense		$	1,029

Ref (b): Unrecognized stock expense related to current year's equity grants of restricted stock units to non-employee directors in accordance with DLH compensation policy for non-employee directors.

Schedule of Stock Option Activity



					(in years)
					Weighted
			Weighted		Average	(in thousands)
	(in thousands)		Average		Remaining	Aggregate
	Number of		Exercise		Contractual	Intrinsic
	Shares		Price		Term	Value
Options outstanding September 30, 2018	2,134		$	4.33	6.2	$	5,103
Granted	35		$	5.25	—	—
Exercised	(35	)	$	1.12	—	—
Options outstanding, March 31, 2019	2,134		$	4.36	6.2	$	8,056

Schedule of Option Shares Outstanding, Vested and Expected to Vest

Stock options shares outstanding, vested and unvested for the period ended



		(in thousands)
		March 31,	September 30,
	Ref	2019	2018
Vested and exercisable	(a)	1,300	1,335
Unvested		834	799
Options outstanding		2,134	2,134

Ref (a): Certain awards vest upon satisfaction of certain performance criteria.

Earnings Per Share (Tables)

6 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Schedule of Diluted Earnings per Share

Diluted earnings per share is calculated using the treasury stock method.



	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2019		2018		2019		2018
Numerator:
Net income (loss)	$	1,265	$	1,316	$	2,955	$	(1,535	)
Denominator:
Denominator for basic net income (loss) per share - weighted-average outstanding shares	12,036		11,889		11,999		11,863
Effect of dilutive securities:
Stock options and restricted stock	1,051		997		1,031		—
Denominator for diluted net income (loss) per share - weighted-average outstanding shares	13,087		12,886		13,030		11,863

Net income (loss) per share - basic	$	0.11	$	0.11	$	0.25	$	(0.13	)
Net income (loss) per share - diluted	$	0.10	$	0.10	$	0.23	$	(0.13	)

Commitment and Contingencies (Tables)

6 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of Contractual Obligations

Contractual obligations as of March 31, 2019



			Payments Due By Period
			Next 12		2-3		4-5		More than 5
(Amounts in thousands)	Total		Months		Years		Years		Years
Facility leases	$	2,315	$	912	$	694	$	680	$	29
Equipment operating leases	27		16		11		—		—
Total obligations	$	2,342	$	928	$	705	$	680	$	29

Business Overview (Details)	6 Months Ended
Business Overview (Details)	Mar. 31, 2019 employee contract location option	Mar. 31, 2018
Revenue concentration \| Customer concentration \| US Federal Government
Concentration Risk [Line Items]
Concentration risk percentage	100.00%
Revenue concentration \| Customer concentration \| VA
Concentration Risk [Line Items]
Concentration risk percentage	67.00%	63.00%
Number of contracts	16
Revenue concentration \| Customer concentration \| VA \| Pharmacy Services
Concentration Risk [Line Items]
Concentration risk percentage	58.00%
Number of contracts	9
Revenue concentration \| Customer concentration \| VA \| Logistic Services
Concentration Risk [Line Items]
Number of contracts	7
Revenue concentration \| Customer concentration \| HHS
Concentration Risk [Line Items]
Concentration risk percentage	31.00%	33.00%
Revenue concentration \| Customer concentration \| Defense/VA
Concentration Risk [Line Items]
Concentration risk percentage	69.00%
Revenue concentration \| Customer concentration \| Human Services and Solutions
Concentration Risk [Line Items]
Concentration risk percentage	29.00%
Revenue concentration \| Customer concentration \| Public Health/Life Sciences
Concentration Risk [Line Items]
Concentration risk percentage	2.00%
Revenue concentration \| Customer concentration \| Public Health/Life Sciences \| Time and materials
Concentration Risk [Line Items]
Concentration risk percentage	97.00%
Revenue concentration \| Customer concentration \| Public Health/Life Sciences \| Cost plus fixed fee
Concentration Risk [Line Items]
Concentration risk percentage	2.00%
Revenue concentration \| Customer concentration \| Public Health/Life Sciences \| Firm fixed price
Concentration Risk [Line Items]
Concentration risk percentage	1.00%
Revenue concentration \| Customer concentration \| Head Start Program
Concentration Risk [Line Items]
Concentration risk percentage	28.00%	31.00%
Revenue concentration \| Customer concentration \| Head Start Program \| Time and materials
Concentration Risk [Line Items]
Government contract, number of option periods \| option	4
Government contract, term of award	5 years
Revenue concentration \| Revenue from Rights Concentration Risk \| Prime
Concentration Risk [Line Items]
Concentration risk percentage	99.00%
Revenue concentration \| Revenue from Rights Concentration Risk \| Subcontractor
Concentration Risk [Line Items]
Concentration risk percentage	1.00%
UNITED STATES
Concentration Risk [Line Items]
Number of employees \| employee	1,600
Number of locations in which entity operates \| location	30

Revenue Recognition - Narrative (Details) $ in Thousands	Oct. 01, 2018 USD ($)
ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of adoption of new accounting pronouncement in opening balance sheet (less than)	$ 10

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Revenue from Contract with Customer [Abstract]
Contract assets	$ 183	$ 214
Contract liabilities	$ 0	$ 0

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Disaggregation of Revenue [Line Items]
Total Revenue	$ 33,756	$ 34,401	$ 67,508	$ 64,616
Prime
Disaggregation of Revenue [Line Items]
Total Revenue	33,538		67,066
Subcontractor
Disaggregation of Revenue [Line Items]
Total Revenue	218		442
Time and materials
Disaggregation of Revenue [Line Items]
Total Revenue	32,625		65,415
Cost plus fixed fee
Disaggregation of Revenue [Line Items]
Total Revenue	637		1,246
Firm fixed price
Disaggregation of Revenue [Line Items]
Total Revenue	494		847
Department of Veterans Affairs
Disaggregation of Revenue [Line Items]
Total Revenue	23,197		46,008
Department of Health and Human Services
Disaggregation of Revenue [Line Items]
Total Revenue	9,706		19,973
Other
Disaggregation of Revenue [Line Items]
Total Revenue	$ 853		$ 1,527

Supporting Financial Information - Accounts Receivable (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Billed receivables	$ 9,213	$ 10,066
Contract assets	183	214
Total accounts receivable	9,396	10,280
Less: Allowance for doubtful accounts	0	0
Accounts receivable, net	$ 9,396	$ 10,280

Supporting Financial Information - Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid insurance and benefits	$ 737	$ 401
Other receivables and prepaid expenses	772	359
Other current assets	$ 1,509	$ 760

Supporting Financial Information - Equipment and Improvements, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2018
Property, Plant and Equipment [Line Items]
Furniture and equipment	$ 326		$ 326		$ 326
Computer equipment	748		748		751
Computer software	1,738		1,738		1,731
Leasehold improvements	66		66		66
Total equipment and improvements	2,878		2,878		2,874
Less accumulated depreciation and amortization	(1,550)		(1,550)		(1,308)
Equipment and improvements, net	1,328		$ 1,328		$ 1,566
Minimum
Property, Plant and Equipment [Line Items]
Estimated useful of long-lived assets			3 years
Maximum
Property, Plant and Equipment [Line Items]
Estimated useful of long-lived assets			7 years
Leasehold Improvements \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful of long-lived assets			3 years
Leasehold Improvements \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful of long-lived assets			7 years
Equipment
Property, Plant and Equipment [Line Items]
Depreciation of equipment	$ 100	$ 100	$ 200	$ 200

Supporting Financial Information - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2018
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 17,623		$ 17,623		$ 17,623
Total accumulated amortization	(5,140)		(5,140)		(4,258)
Intangible assets, net	12,483		$ 12,483		13,365
Estimated useful live of intangible assets			10 years
Amortization expense of intangible assets	400	$ 400	$ 900	$ 900
Customer contracts and related customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	16,626		16,626		16,626
Total accumulated amortization	(4,850)		(4,850)		(4,018)
Covenants not to compete
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	480		480		480
Total accumulated amortization	(140)		(140)		(116)
Trade name
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	517		517		517
Total accumulated amortization	$ (150)		$ (150)		$ (124)

Supporting Financial Information - Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Remaining Fiscal 2019	$ 883
Fiscal 2020	1,762
Fiscal 2021	1,762
Fiscal 2022	1,762
Fiscal 2023	1,762
Thereafter	4,552
Intangible assets, net	$ 12,483	$ 13,365

Supporting Financial Information - Accounts Payable, Accrued Expense and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts payable	$ 3,818	$ 3,393
Accrued benefits	2,150	2,060
Accrued bonus and incentive compensation	1,051	2,191
Accrued workers compensation insurance	3,465	2,642
Other accrued expenses	821	664
Accounts payable, accrued expenses, and other current liabilities	$ 11,305	$ 10,950

Supporting Financial Information - Debt Obligations (Details) - Debt obligations - USD ($) $ in Thousands	Mar. 31, 2019	Sep. 30, 2018
Debt Instrument [Line Items]
Bank term loan	$ 0	$ 7,708
Less unamortized debt issuance costs	0	(750)
Net bank debt obligation	0	6,958
Less current portion of bank debt obligations	0	0
Long term portion of bank debt obligation	$ 0	$ 6,958

Supporting Financial Information - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest expense	$ (83)	$ (208)	$ (187)	$ (427)
Amortization of deferred financing costs	(461)	(67)	(534)	(132)
Other income (expense), net	0	14	0	20
Interest expense, net	(544)	$ (261)	(721)	$ (539)
Write-off of remaining financing costs related to debt fully satisfied	$ 400		$ 400

Credit Facilities - Loan Facilities and Subordinated Debt (Details) - Secured Debt - Fifth Third Bank Credit Facility	6 Months Ended
	Mar. 31, 2019 USD ($)
Term Loans
Line of Credit Facility [Line Items]
Secured term loan, face amount	$ 25,000,000
Total bank debt obligation	$ 0
Term Loans \| LIBOR
Line of Credit Facility [Line Items]
Interest rate percentage	2.49%
Basis spread on variable rate percentage	3.00%
Line of Credit
Line of Credit Facility [Line Items]
Secured revolving line of credit, ceiling	$ 10,000,000
Total bank debt obligation	$ 0
Line of Credit \| LIBOR
Line of Credit Facility [Line Items]
Basis spread on variable rate percentage	3.00%

Credit Facilities - Narrative (Details) - Secured Debt - Fifth Third Bank Credit Facility	1 Months Ended	6 Months Ended
	Sep. 30, 2018 USD ($)	Mar. 31, 2019 USD ($)
Term Loans
Line of Credit Facility [Line Items]
Secured term loan, face amount		$ 25,000,000
Number of equal installment payments		59 months
Monthly installment payments		$ 312,500
Fixed charge coverage ratio		1.35
Ratio of debt to EBITDA at closing at thereafter		2.99
Ratio of debt to EBDTA for the period through December 31, 2017		3.0
Ratio of debt to EBDTA for the period ending September 30, 2018 through maturity		2.5
Voluntary repayments of lines of credit	$ 5,600,000
Term Loans \| Excess Cash Flows Greater Than Or Equal to 2.50
Line of Credit Facility [Line Items]
Percentage of excess cash flow for each year of funded indebtedness to EBDTA		75.00%
Ratio of funded indebtedness to adjusted EBDTA, actual		2.50
Term Loans \| Excess Cash Flows Less Than 2.50 Greater Than 2.00
Line of Credit Facility [Line Items]
Percentage of excess cash flow for each year of funded indebtedness to EBDTA		50.00%
Term Loans \| Maximum \| Excess Cash Flows Less Than 2.50 Greater Than 2.00
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to adjusted EBDTA, actual		2.50
Term Loans \| Minimum \| Excess Cash Flows Less Than 2.50 Greater Than 2.00
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to adjusted EBDTA, actual		2.0
Line of Credit
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing capacity		$ 10,000,000
Line of credit, current borrowing capacity		7,200,000
Line of credit, unused borrowing capacity		8,300,000
Letter of Credit
Line of Credit Facility [Line Items]
Line of credit, current borrowing capacity		$ 1,100,000

Significant Accounting Policies (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Significant Accounting Policies (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2018
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill	$ 25,989,000		$ 25,989,000		$ 25,989,000
Goodwill impairment					0
Uncertain tax positions	0		0		$ 0
Income tax interest expense	0	$ 0	0	$ 0
Income tax penalties expense	0	$ 0	0	$ 0
Cash, FDIC insured amount	$ 250,000		$ 250,000
Employee Stock Option
Acquired Indefinite-lived Intangible Assets [Line Items]
Number of awards authorized for issuance (in shares)	0		0
Expiration term of share-based compensation plan			10 years
Minimum
Acquired Indefinite-lived Intangible Assets [Line Items]
Estimated useful of long-lived assets			3 years
Maximum
Acquired Indefinite-lived Intangible Assets [Line Items]
Estimated useful of long-lived assets			7 years

Stock-based Compensation, Equity Grants, and Warrants - Narrative (Details) - Employee Stock Option	6 Months Ended
	Mar. 31, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards authorized for issuance (in shares)	0
Expiration term of share-based compensation plan	10 years
Number of shares available for grant (in shares)	1,500,000

Stock-based Compensation, Equity Grants, and Warrants - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock option expense	$ 199	$ 171	$ 392	$ 928
Number of options granted (in shares)			35,000
Total unrecognized expense	1,029		$ 1,029
Weighted average share based compensation expense recognition period			3 years 4 months 2 days
DLH employees
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of options granted (in shares)			35,000
DLH employees \| Selling, General and Administrative Expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock option expense	67	67	$ 129	131
Total unrecognized expense	$ 766		766
Non-employee directors \| Restricted Stock Units
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)	90,000
Non-employee directors \| Selling, General and Administrative Expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock option expense	$ 132	$ 104	263	$ 797
Total unrecognized expense	$ 263		$ 263

Stock-based Compensation, Equity Grants, and Warrants - Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Mar. 31, 2019	Sep. 30, 2018
Number of Shares
Outstanding at the beginning of the period (in shares)	2,134
Granted (in shares)	35
Exercised (in shares)	(35)
Outstanding at the end of the period (in shares)	2,134	2,134
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 4.33
Granted (in dollars per share)	5.25
Exercised (in dollars per share)	1.12
Outstanding at the end of the period (in dollars per share)	$ 4.36	$ 4.33
Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term	6 years 2 months 12 days	6 years 2 months 12 days
Aggregate Intrinsic Value
Outstanding at the beginning of the period (in dollars)	$ 5,103
Outstanding at the end of the period (in dollars)	$ 8,056	$ 5,103

Stock-based Compensation, Equity Grants, and Warrants - Stock Options Outstanding, Vested and Unvested (Details) - shares shares in Thousands	Mar. 31, 2019	Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Vested and exercisable (in shares)	1,300	1,335
Unvested (in shares)	834	799
Option outstanding (in shares)	2,134	2,134

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Numerator:
Net income (loss)	$ 1,265	$ 1,316	$ 2,955	$ (1,535)
Denominator:
Denominator for basic net income (loss) per share - weighted-average outstanding shares (shares)	12,036	11,889	11,999	11,863
Effect of dilutive securities:
Stock options and restricted stock (shares)	1,051	997	1,031	0
Denominator for diluted net income (loss) per share - weighted-average outstanding shares (shares)	13,087	12,886	13,030	11,863
Net income per share, basic (in dollars per share)	$ 0.11	$ 0.11	$ 0.25	$ (0.13)
Net income per share - diluted (in dollars per share)	$ 0.10	$ 0.10	$ 0.23	$ (0.13)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686